Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

NCT02504489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Memorial Health Care System Colorado Springs, Colorado, United States
View all 57 locations
View Trial Details
Completed

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

NCT03409614

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Regeneron Research Site Rancho Mirage, California, United States
  • Regeneron Research Site Riverside, California, United States
  • Regeneron Research Site Whittier, California, United States
  • Regeneron Research Site Orange City, Florida, United States
View all 133 locations
View Trial Details
Completed

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

NCT02438722

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Fowler Family Center for Cancer Care Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 638 locations
View Trial Details
Completed

Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer

NCT01350817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Service de Pneumologie, CHU Angers Angers, France
  • Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France
  • Service de Pneumologie; Centre Hospitalier Beauvais, France
  • Service de Pneumologie Beauvais, France
View all 30 locations
View Trial Details
Completed

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

NCT04087473

Conditions
ALK-Positive Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • The Chinese University of Hong Kong Hong Kong
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • National Cancer Center Singapore Singapore
  • Asan Medical Centre Seoul, South Korea
View Trial Details
Completed

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

NCT04042558

Conditions
ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations
  • CHU Angers, France
  • Centre Hospitalier Annecy, France
  • CHU-Hôpital MORVAN Brest, France
  • CHU Lyon Louis Pradel Bron, France
View all 31 locations
View Trial Details

Related conditions